The safety and tolerability of levodopa eye drops for the treatment of ocular disorders: A randomized first‐in‐human study

Myopia is the leading cause of low vision worldwide and can lead to significant pathological complications. Therefore, to improve patient outcomes, the field continues to develop novel interventions for this visual disorder. Accordingly, this first‐in‐human study reports on the safety profile of a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, Kate, Karouta, Cindy, Sabeti, Faran, Anstice, Nicola, Leung, Myra, Jong, Tina, Maddess, Ted, Morgan, Ian G., Game, Jeremy, Ashby, Regan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652433/
https://www.ncbi.nlm.nih.gov/pubmed/36221799
http://dx.doi.org/10.1111/cts.13392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652433/
https://www.ncbi.nlm.nih.gov/pubmed/36221799
http://dx.doi.org/10.1111/cts.13392

Ejemplares similares